|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash from operating activities | |||||
| Time deposits amortization | |||||
| Security amortization, net | |||||
| Depreciation | |||||
| Amortization of core deposit intangible | |||||
| Accretion of net deferred loan fees and purchase discounts | |||||
| Loss (gain) on sale of fixed assets | |||||
| Net gain on sale of OREO properties | |||||
| Net gain on sale of securities | |||||
| Net (gain) loss on equity securities | |||||
| Provision for credit losses | |||||
| Loans and leases originated for sale | |||||
| Proceeds from sale of loans and leases | |||||
| Net gain on sale of loans and leases | |||||
| Increase in cash surrender value of bank owned life insurance | |||||
| Share-based compensation | |||||
| Deferred taxes | |||||
| Accrued interest payable | |||||
| Accrued interest receivable | |||||
| Cash collateral posted by derivative counterparties | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows used for investing activities: | |||||
| Maturities | |||||
| Purchases | |||||
| Maturities, prepayments and calls | |||||
| Sales of securities, available for sale | |||||
| Purchases of securities, available for sale | |||||
| Purchases of other securities | |||||
| Redemption of other securities | |||||
| Purchases of bank owned life insurance | |||||
| Proceeds from bank owned life insurance | |||||
| Net change in loans | |||||
| Proceeds from sale of OREO properties | |||||
| Cash received from acquisitions, net | |||||
| Premises and equipment purchases | |||||
| Disposal of premises and equipment | |||||
| Net cash provided by (used) in investing activities | |||||
| Cash flows from financing activities: | |||||
| Increase (decrease) in deposits | |||||
| Net change in short-term FHLB advances | |||||
| Repayment of long-term FHLB advances | |||||
| Net proceeds from common stock issuance | |||||
| Change in other borrowings | |||||
| Increase (decrease) in securities sold under repurchase agreements | |||||
| Repurchase of common stock | |||||
| Cash dividends paid | |||||
| Net cash (used) provided by financing activities | |||||
| Increase (decrease) in cash and due from financial institutions | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Transfer of loans from portfolio to other real estate owned | |||||
| Securities purchased not settled | |||||
| The Company purchased all of the capital stock. In conjunction with the acquisitions, liabilities were assumed as follows: | |||||
| Fair value of assets acquired | |||||
| Farmers Savings Bank | |||||
| Less: common stock issued | |||||
| Farmers Savings Bank | |||||
| Liabilities assumed | |||||
| Farmers Savings Bank | |||||
Loading...